| 000 | 01711 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515190237.0 | ||
| 264 | 0 | _c20091211 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1615-2573 | ||
| 024 | 7 |
_a10.1007/s00380-008-1128-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTan, Jing | |
| 245 | 0 | 0 |
_aPrognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. _h[electronic resource] |
| 260 |
_bHeart and vessels _cSep 2009 |
||
| 300 |
_a329-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCD40 Ligand _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xblood |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _ximmunology |
| 650 | 0 | 4 | _aPatient Admission |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aHua, Qi | |
| 700 | 1 | _aLi, Jing | |
| 700 | 1 | _aFan, Zhenxing | |
| 773 | 0 |
_tHeart and vessels _gvol. 24 _gno. 5 _gp. 329-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00380-008-1128-8 _zAvailable from publisher's website |
| 999 |
_c19181245 _d19181245 |
||